Cell-based drug delivery systems and their in vivo fate
L Yang, Y Yang, Y Chen, Y Xu, J Peng - Advanced Drug Delivery Reviews, 2022 - Elsevier
Cell-based drug delivery systems (DDSs) have received attention recently because of their
unique biological properties and self-powered functions, such as excellent biocompatibility …
unique biological properties and self-powered functions, such as excellent biocompatibility …
Drug delivery by red blood cells: vascular carriers designed by mother nature
VR Muzykantov - Expert opinion on drug delivery, 2010 - Taylor & Francis
Importance of the field: Vascular delivery of several classes of therapeutic agents may
benefit from carriage by red blood cells (RBC), for example, drugs that require delivery into …
benefit from carriage by red blood cells (RBC), for example, drugs that require delivery into …
Non-genetic engineering of cells for drug delivery and cell-based therapy
Cell-based therapy is a promising modality to address many unmet medical needs. In
addition to genetic engineering, material-based, biochemical, and physical science-based …
addition to genetic engineering, material-based, biochemical, and physical science-based …
Photophysical pore control in an azobenzene-containing metal–organic framework
JW Brown, BL Henderson, MD Kiesz, AC Whalley… - Chemical …, 2013 - pubs.rsc.org
The synthesis and structure of an azobenzene functionalized isoreticular metal–organic
framework (azo-IRMOF-74-III)[Mg2 (C26H16O6N2)] are described and the ability to …
framework (azo-IRMOF-74-III)[Mg2 (C26H16O6N2)] are described and the ability to …
Dual affinity to RBCs and target cells (DART) enhances both organ-and cell type-targeting of intravascular nanocarriers
LT Ferguson, ED Hood, T Shuvaeva, VV Shuvaev… - ACS …, 2022 - ACS Publications
A long-standing goal of nanomedicine is to improve a drug's benefit by loading it into a
nanocarrier that homes solely to a specific target cell and organ. Unfortunately, nanocarriers …
nanocarrier that homes solely to a specific target cell and organ. Unfortunately, nanocarriers …
Cell-based drug delivery
Drug delivery has been greatly improved over the years by means of chemical and physical
agents that increase bioavailability, improve pharmacokinetic and reduce toxicities. At the …
agents that increase bioavailability, improve pharmacokinetic and reduce toxicities. At the …
[HTML][HTML] Erythrocytes as carriers: From drug delivery to biosensors
L Koleva, E Bovt, F Ataullakhanov, E Sinauridze - Pharmaceutics, 2020 - mdpi.com
Drug delivery using natural biological carriers, especially erythrocytes, is a rapidly
developing field. Such erythrocytes can act as carriers that prolong the drug's action due to …
developing field. Such erythrocytes can act as carriers that prolong the drug's action due to …
Drug, enzyme and peptide delivery using erythrocytes as carriers
CG Millan, MLS Marinero, AZ Castaneda… - Journal of controlled …, 2004 - Elsevier
Erythrocytes are potential biocompatible vectors for different bioactive substances, including
drugs. These can be used successfully as biological carriers of drugs, enzymes and …
drugs. These can be used successfully as biological carriers of drugs, enzymes and …
Applications of carrier erythrocytes in delivery of biopharmaceuticals
M Hamidi, A Zarrin, M Foroozesh… - Journal of controlled …, 2007 - Elsevier
Carrier erythrocytes, resealed erythrocytes loaded by a drug or other therapeutic agents,
have been exploited extensively in recent years for both temporally and spatially controlled …
have been exploited extensively in recent years for both temporally and spatially controlled …
Open-field handheld fluorescence imaging systems and methods
PR Westwick - US Patent 11,140,305, 2021 - Google Patents
An imaging device having an imaging field of view, the imaging device including at least one
illumination port configured to output light for illuminating a target; an imaging sensor to …
illumination port configured to output light for illuminating a target; an imaging sensor to …